Uffe H. Olesen

Anticancer agent CHS-828 inhibits cellular synthesis of NAD

Uffe H. Olesen, Mette Knak Christensen, Fredrik Björkling et al. · Biochemical and Biophysical Research Communications · 2008 · 116 citations

Medicine, Oncology, Pharmacology +12

A Preclinical Study on the Rescue of Normal Tissue by Nicotinic Acid in High-Dose Treatment with APO866, a Specific Nicotinamide Phosphoribosyltransferase Inhibitor

Uffe H. Olesen, Annemette Thougaard, Peter Buhl Jensen et al. · Molecular Cancer Therapeutics · 2010 · 76 citations

Medicine, Oncology, Pharmacology +9

Fractional laser-assisted topical delivery leads to enhanced, accelerated and deeper cutaneous 5-fluorouracil uptake

Emily Wenande, Uffe H. Olesen, Mette M. B. Nielsen et al. · Expert Opinion on Drug Delivery · 2016 · 74 citations

Medicine, Oncology, Pharmacology +15

Expression patterns of nicotinamide phosphoribosyltransferase and nicotinic acid phosphoribosyltransferase in human malignant lymphomas

Uffe H. Olesen, Nina Hastrup, Maxwell Sehested · Apmis · 2011 · 66 citations

Medicine, Oncology, Pharmacology +15

Target enzyme mutations are the molecular basis for resistance towards pharmacological inhibition of nicotinamide phosphoribosyltransferase

Uffe H. Olesen, Jakob Gramstrup Petersen, Antje Garten et al. · BMC Cancer · 2010 · 52 citations · Full text

Medicine, Oncology, Pharmacology +15